BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $3.98 | Prev. Close $4.03 | Circuit Range N/A |
Day Range $3.98 - $4.00 | Year Range $0.61 - $13.78 | Volume 350 |
Average Traded $3.98 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Apr-26 | $3.98 | $4.00 | +0.00% |
29-Apr-26 | $3.98 | $4.00 | -1.58% |
28-Apr-26 | $3.94 | $4.06 | +0.22% |
27-Apr-26 | $3.92 | $4.05 | +2.79% |
24-Apr-26 | $3.78 | $3.94 | +6.06% |
23-Apr-26 | $3.90 | $3.71 | -5.23% |
22-Apr-26 | $3.90 | $3.92 | -1.63% |